Live attenuated intranasal influenza vaccine (Q37976534)

26 August 2017

Live attenuated intranasal influenza vaccine. (English)

1 reference

26 August 2017

1 reference

1 reference

1

1 reference

26 August 2017

6

Nicola Principi

1 reference

26 August 2017

5

Margherita Semino

1 reference

26 August 2017

4

Rossana Tenconi

1 reference

26 August 2017

2

Valentina Montinaro

1 reference

26 August 2017

Elena Groppali

3

1 reference

26 August 2017

1 January 2012

1 reference

Human Vaccines & Immunotherapeutics

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

1

1 reference

26 August 2017

76-80

1 reference

Influenza vaccination coverage among high-risk groups in 11 European countries.

26 August 2017

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Different influenza vaccine formulations and adjuvants for childhood influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

A systematic review of intradermal influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Comparative efficacy of inactivated and live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.8.1.18809

21 January 2018

Identifiers

DOI

10.4161/HV.8.1.18809

1 reference

26 August 2017

1 reference

PubMed ID

22251995